MedTrace Logo

The Effects of Fermented Brown Seaweed Intake on Glucose Metabolism and Gut Health

NCT06418763 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-07-31

No results posted yet for this study

Summary

The aim of this randomised, controlled, cross-over study is to investigate whether the intake of fermented brown seaweed can lower postprandial blood glucose levels and influence the composition of the gut microbiota in 25 healthy volunteers. Well-being and gastrointestinal symptoms as well as sensory properties of the products will also be evaluated using questionnaires.

At the screening visit, the subjects will be informed about the study procedures and inclusion/exclusion criteria will be checked. Informed consent will be signed by each subject before participating in the study. The participants will consume the active and control product, respectively, for 5 days with a 14-day wash-out period in between. Capillary blood samples will be drawn for glucose measurement at the first day of each 5-day intervention period. Faecal samples will be collected before and after each 5-day intervention period to analyse changes in gut microbial composition.

Conditions

  • Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

Baobab spread mixed with fermented brown seaweed

5-day intake period

DIETARY_SUPPLEMENT

Baobab spread

5-day intake period

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Carbiotix AB

    collaborator INDUSTRY

  • Aventure AB

    lead INDUSTRY

Principal Investigators

  • Lieselotte Cloetens · Lund University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-22
Primary Completion
2024-06-30
Completion
2025-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06418763 on ClinicalTrials.gov